Navigation Links
Asymptomatic HIV babies could use earlier treatment

Identifying and treating HIV-infected newborns is a race against the clock, according to a study from the Stanford University School of Medicine and Lucile Packard Children’s Hospital. Researchers found that HIV-infected infants treated with one or two antiretroviral drugs within two months of birth were less likely to develop AIDS by their third birthday than were infants who were 3 or 4 months old when treatment was initiated. Infants who received a combination of three antiretroviral drugs did even better.

“This is an important finding because there’s been a lot of controversy in the literature as to whether infected but asymptomatic infants should be started on therapy right away,?said the study’s senior author Yvonne Maldonado, MD, a pediatric infectious disease expert at Lucile Packard Children’s Hospital and an associate professor of pediatrics at Stanford’s School of Medicine.

Without any kind of treatment, about 20 to 30 percent of HIV-infected infants will develop AIDS by around 4 months of age. The rest will not have advanced symptoms until they are about 6 years old. The study, published May 11 in the Journal of the American Medical Association, suggests that early treatment might be appropriate for at least some apparently healthy infected infants.

“There is a significant difference in the likelihood of disease progression [with earlier treatment], even though there is only about a month separating the initiation of therapy in the two groups,?Maldonado said. “And none of the children who received triple therapy progressed to AIDS before their third birthday, regardless of the age at which they began therapy.?(Therapy with a combination of three drugs, known as highly active antiretroviral therapy, or HAART, was not available when the study began in 1988.)

Current guidelines for treating HIV-infected infants leave the decision of when to begin treatment to the child’s physician—in part because the long-term effects of ongoi
'"/>

Source:Stanford University


Page: 1 2 3

Related biology news :

1. OHSU research shows vitamin C counteracts some negative impacts of smoking on unborn babies
2. New brain scan technology could save babies lives
3. New tool tracks brain development in babies
4. Todays babies are fatter babies
5. Research offers new hope for preterm babies
6. Hair samples show babies can be exposed to crystal meth while in the womb
7. Solvent exposure linked to birth defects in babies of male painters
8. Designer babies - what would you do for a healthy baby?
9. Why do cold animals make bigger babies?
10. A revolution in the monitoring of unborn babies
11. Thymus transplants gives hope to babies with fatal immune disease

Post Your Comments:
(Date:11/23/2009)... CINCINNATINew research presents strong evidence t...e to both outdoor traffic-related pollution and in...s than one or the other exposure alone. , Envi...incinnati (UC) College of Medicine have shown that...elated particles and indoor endotoxin during early...
(Date:11/23/2009)..., TORONTO, November 23, 2009 - The time of day ma...ing to a new paper produced by a research team led...nto Scarborough,s vice-principal for research and ...iology at the St. George campus. , Capitalizin...he poplar tree, the research team examined how pop...
(Date:11/23/2009)... Farmington, CT Current research suggests that a ...sease. The related report by Nichols et al, "Uniq...a New Class of TLR2 Ligands Capable of Enhancing A...f The American Journal of Pathology . , Multipl...m attacks the brain and spinal cord, affects nearl...
Breaking Biology News(10 mins):Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Time of day matters to thirsty trees, U of T researcher discovers 2Factors from common human bacteria may trigger multiple sclerosis 2FDA Approves NovoLog 28R 29 Labeling Update 51814 1FDA Approves NovoLog 28R 29 Labeling Update 51814 2FDA Approves NovoLog 28R 29 Labeling Update 51814 3FDA Approves NovoLog 28R 29 Labeling Update 51814 4Fraternal Order of Eagles Award 24630 000 in Grants at International Convention 51809 1Fraternal Order of Eagles Award 24630 000 in Grants at International Convention 51809 2Tube Feeding Error 3A Fatal Medical Mistakes 51804 1Tube Feeding Error 3A Fatal Medical Mistakes 51804 2Tube Feeding Error 3A Fatal Medical Mistakes 51804 3
...d the first clear example of how climate extremes ...ormally tolerated singly may converge and bring ab...ued June 25 by PLoS ONE, an online peer-reviewed...of canine distemper virus (CDV) in 1994 and 2001 t...eti lions. CDV cycles periodically within the Sere...
...K. have discovered that our own body not only make...ent in marijuana (THC), but these play an importa... on "endocannabinoids" just published online in, a... The FASEB Journal could lead to new drugs that t..., and even skin-related tumors. , "Our preclinic...
...rsity faculty member who uses computational techni...gs is attracting worldwide attention from other re...r of chemical and biomedical engineering at the Fl...ege of Engineering, is using high-powered computer... immunotoxins can best be modified in order to att...
Other Biology News:FSU researcher using computers to hone cancer-fighting strategies 2
(Date:11/24/2009)...ble in German . , Whether it,s CD packaging...adio Frequency Identification) are increasingly fi...ossible to label objects or goods and identify the...e scanner can read and process the data contained ... under production conditions of up to 100 degrees ...
(Date:11/24/2009)...Nov.24/PRNewswire/--Twomoreprestigiousuniversities...jobboardandcareerssiteforlifescienceprofessionals....ersofthejobboard,joining28othermajorlifesciencetra...rcenter.com ,isonlyforpost-graduatesinthelifescien...ntheInternet,BioCareerCenteristheonlyonethatserves...
(Date:11/24/2009)... Health care employment grew by 29,000 jobs in O... consistent growth during the U.S. recession. Howe...uble, and health systems are coming closer to havi...ust administrators. , (Vo...ontinued growing in October despite the shedding o...
(Date:11/24/2009)...RNewswire-Asia/--ShanghaiBiolaxyannouncedthe,Chine...dthe,investigationalnewdrugapplication(IND)foritso...ulationtotreatdiabetes.ThisIND,approvalallowsBiola...abetesisadisordercharacteristicofhighbloodglucosea...esultinseveremicro-and,macro-vasculardiseases,loss...
Breaking Biology Technology:Intelligence inside metal components 2Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2
...neered metamaterial proved it can function as a st...ge of the electromagnetic spectrum, setting a stan...adiation, according to a team of researchers from ...l laboratories, and Boston University. , An elect...d structure of metallic split-ring resonators con...
... today announced the development of a unique film-...ue hydration to the passivation of medical device ... of patent-pending polymers that allow Particle Sc...ys Andrew Loxley, PS, Director of New Technologies...em to develop an ocular formulation for one of its...
...unched www.EyeScience.com to fill a large consum...n on age-related macular degeneration (AMD) in a u...essive, hereditary eye disease that is the leading... , , On the site, visitors can learn about basic ..., signs and symptoms and treatments for AMD. In ad...
Other Biology Technology:Team develops new metamaterial device 2Team develops new metamaterial device 3Particle Sciences Completes Development of First Product Incorporating its Unique Surface Modification System 2EyeScience Launches Comprehensive Online Resource Devoted to Age-Related Macular Degeneration Education and Prevention 2
Goat Anti-Derlin-2 (C-18) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Dynabeads M-450 Epoxy from Dynal Biotech
Goat Anti-DOCK 2 (E-15) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Mouse Anti-HSV-2 gD Monoclonal Antibody, Unconjugated, Clone 0191 from Santa Cruz Biotechnology, Inc.
Biology Products: